Nilutamide Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Dec 1, 2025 · last update Dec 1, 2025
Manufacturers: Advanz Pharma (US) Corp.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Nilandron, Tablet, 150 mg (NDC 59212-111-14) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Product to expire in March 2026; Discontinuation of the manufacture of the drug | Posted Dec 1, 2025 Updated Dec 1, 2025 Discontinued Dec 1, 2025 |
| Nilandron, Tablet, 150 mg (NDC 66993-212-38) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Product to expire in March 2026; Discontinuation of the manufacture of the drug | Posted Dec 1, 2025 Updated Dec 1, 2025 Discontinued Dec 1, 2025 |